232 related articles for article (PubMed ID: 8630591)
1. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
Roux FJ; Grandordy B; Douglas JS
Am J Respir Crit Care Med; 1996 May; 153(5):1489-95. PubMed ID: 8630591
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.
Teschemacher A; Lemoine H
J Pharmacol Exp Ther; 1999 Mar; 288(3):1084-92. PubMed ID: 10027845
[TBL] [Abstract][Full Text] [Related]
3. [Inquiry into the mechanism of long-acting bronchodilators].
Bao Y; Lemoine H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):191-6. PubMed ID: 11367704
[TBL] [Abstract][Full Text] [Related]
4. Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.
Kikkawa H; Naito K; Ikezawa K
Jpn J Pharmacol; 1991 Oct; 57(2):175-85. PubMed ID: 1687479
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacologic characterization of formoterol in comparison with isoprenaline, fenoterol and salbutamol in tracheal muscle strips and lung membranes of the guinea pig].
Lemoine H; Worth H; Reinhardt D
Pneumologie; 1993 Apr; 47(4):303-10. PubMed ID: 8506253
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices.
Sturton RG; Trifilieff A; Nicholson AG; Barnes PJ
J Pharmacol Exp Ther; 2008 Jan; 324(1):270-5. PubMed ID: 17916760
[TBL] [Abstract][Full Text] [Related]
7. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
[TBL] [Abstract][Full Text] [Related]
8. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
[TBL] [Abstract][Full Text] [Related]
10. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
Naline E; Zhang Y; Qian Y; Mairon N; Anderson GP; Grandordy B; Advenier C
Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
[TBL] [Abstract][Full Text] [Related]
11. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.
Jeppsson AB; Källström BL; Waldeck B
Pharmacol Toxicol; 1992 Oct; 71(4):272-7. PubMed ID: 1360657
[TBL] [Abstract][Full Text] [Related]
12. Formoterol, fenoterol, and salbutamol as partial agonists for relaxation of maximally contracted guinea pig tracheae: comparison of relaxation with receptor binding.
Lemoine H; Overlack C; Köhl A; Worth H; Reinhardt D
Lung; 1992; 170(3):163-80. PubMed ID: 1351970
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
14. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A; Lipworth BJ
Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Grove A; Lipworth BJ
Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
[TBL] [Abstract][Full Text] [Related]
16. Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi.
Molimard M; Naline E; Zhang Y; Le Gros V; Begaud B; Advenier C
Eur Respir J; 1998 Mar; 11(3):583-8. PubMed ID: 9596106
[TBL] [Abstract][Full Text] [Related]
17. The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.
Patel S; Summerhill S; Stanley M; Perros-Huguet C; Trevethick MA
Pulm Pharmacol Ther; 2011 Apr; 24(2):247-55. PubMed ID: 21134482
[TBL] [Abstract][Full Text] [Related]
18. Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.
Suzuki H; Ueno A; Takei M; Sindo K; Miura T; Sakakibara M; Higa T; Fukamachi H
Br J Pharmacol; 1999 Oct; 128(3):716-20. PubMed ID: 10516653
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
Aparici M; Gómez-Angelats M; Vilella D; Otal R; Carcasona C; Viñals M; Ramos I; Gavaldà A; De Alba J; Gras J; Cortijo J; Morcillo E; Puig C; Ryder H; Beleta J; Miralpeix M
J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
[TBL] [Abstract][Full Text] [Related]
20. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol.
Nials AT; Ball DI; Butchers PR; Coleman RA; Humbles AA; Johnson M; Vardey CJ
Eur J Pharmacol; 1994 Jan; 251(2-3):127-35. PubMed ID: 8149969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
